StockNews.com Downgrades Dolby Laboratories (NYSE:DLB) to Buy

Published on 28 Nov 2024 on ETF DAILY NEWS

Rosenblatt Securities raised their price target on Dolby Laboratories from $98.00 to $100.00 and...

Read the rest of the article

Start tracking your investments with Statfolio

Rosenblatt Securities raised their price target on Dolby Laboratories from $98.00 to $100.00 and...

ETF DAILY NEWS 28 Nov 2024

Kevin Yeaman, President and CEO of Dolby Laboratories , Inc. (NYSE:DLB), recently executed a seri...

Investing.com 27 Nov 2024

Raymond James Trust N.A. trimmed its stake in shares of Dolby Laboratories, Inc. (NYSE:DLB – Free...

ETF DAILY NEWS 27 Nov 2024

Dolby Laboratories, Inc. (NYSE:DLB – Free Report) – Equities research analysts at William Blair...

ETF DAILY NEWS 26 Nov 2024

Taking full advantage of the stock market and investing with confidence are common goals for new ...

Zacks · via Yahoo Finance 26 Nov 2024

Dolby Laboratories, Inc. (NYSE:DLB – Free Report) – Stock analysts at Barrington Research cut the...

ETF DAILY NEWS 25 Nov 2024

Thrivent Financial for Lutherans grew its holdings in Dolby Laboratories, Inc. (NYSE:DLB – Free...

ETF DAILY NEWS 23 Nov 2024

SAN FRANCISCO—Peter C. Gotcher, a director at Dolby Laboratories , Inc. (NYSE:DLB), recently sold...

Investing.com 22 Nov 2024

Key Insights Using the 2 Stage Free Cash Flow to Equity, Dolby Laboratories fair value estimate i...

Simply Wall St. · via Yahoo Finance 21 Nov 2024

Dolby Laboratories Inc (DLB) reports a 5% revenue increase and a 25% rise in non-GAAP EPS, driven...

GuruFocus.com · via Yahoo Finance 20 Nov 2024